Gujarat Inject (Kerala) Ltd.
BSE: GUJINJEC · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Gujarat Inject (Kerala) Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gujarat Inject (Kerala) Limited is a pharmaceutical company specialising in the manufacturing and marketing of intravenous fluids and large volume parenterals. It primarily supplies essential medical solutions, such as dextrose and electrolyte formulations, to hospitals and government institutions.
Business Model
The company generates revenue through the production and sale of generic pharmaceutical formulations and intravenous fluids. It operates a manufacturing facility in Kerala to serve clinical and hospital-based demand.
Management Commentary
Management focuses on maintaining manufacturing standards and operational stability within the highly competitive generic pharmaceutical sector.
Growth Outlook
Growth is contingent upon the company's ability to navigate regulatory requirements and maintain its position as a niche supplier of essential medical fluids.
Key Risks
- Regulatory Compliance. The company faces ongoing risks related to stringent pharmaceutical manufacturing standards and potential regulatory audits.
- Market Competition. Intense competition in the generic pharmaceutical landscape may pressure profit margins and market share.
- Financial Volatility. Historical financial instability poses a risk to the company's ability to fund operations and capital expenditure.
- Input Cost Inflation. Fluctuations in the cost of raw materials and energy can significantly impact the production costs of intravenous fluids.
Start your research today
Unlock AI insights, financials, peers and live data on Gujarat Inject (Kerala) Ltd. and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gujarat Inject (Kerala) Ltd.GUJINJEC | ₹169 Cr | — | — | — | 6.3% | — | — | -46.8% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Gujarat Inject (Kerala) Ltd.
BSE: GUJINJEC · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Gujarat Inject (Kerala) Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gujarat Inject (Kerala) Limited is a pharmaceutical company specialising in the manufacturing and marketing of intravenous fluids and large volume parenterals. It primarily supplies essential medical solutions, such as dextrose and electrolyte formulations, to hospitals and government institutions.
Business Model
The company generates revenue through the production and sale of generic pharmaceutical formulations and intravenous fluids. It operates a manufacturing facility in Kerala to serve clinical and hospital-based demand.
Management Commentary
Management focuses on maintaining manufacturing standards and operational stability within the highly competitive generic pharmaceutical sector.
Growth Outlook
Growth is contingent upon the company's ability to navigate regulatory requirements and maintain its position as a niche supplier of essential medical fluids.
Key Risks
- Regulatory Compliance. The company faces ongoing risks related to stringent pharmaceutical manufacturing standards and potential regulatory audits.
- Market Competition. Intense competition in the generic pharmaceutical landscape may pressure profit margins and market share.
- Financial Volatility. Historical financial instability poses a risk to the company's ability to fund operations and capital expenditure.
- Input Cost Inflation. Fluctuations in the cost of raw materials and energy can significantly impact the production costs of intravenous fluids.
Start your research today
Unlock AI insights, financials, peers and live data on Gujarat Inject (Kerala) Ltd. and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026